Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Exner
Agata Exner, Westlake, OH US
| Patent application number | Description | Published |
|---|---|---|
| 20080206187 | METHOD FOR TREATING A NEOPLASTIC DISORDER - A method for treating a neoplastic disorder in a subject includes administering to the neoplastic cells a neoplastic cell-sensitizing composition including a poly(ethylene oxide)-poly(propylene oxide) copolymer. The poly(ethylene oxide)-poly(propylene oxide) copolymer can sensitize the neoplastic cells to hyperthermia. Energy can be applied to the neoplastic cells to heat and ablate the cells. | 08-28-2008 |
Agata A. Exner, Westlake, OH US
| Patent application number | Description | Published |
|---|---|---|
| 20100080757 | METHOD OF DETECTING ABNORMAL TISSUE - A method for detecting abnormal biological tissue includes administering a vasoactive agent and determining the rate of blood flow in a tissue of interest. | 04-01-2010 |
Bill Exner, Mission Viejo, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110142687 | FLOOD WATER REMOVAL SYSTEM - Flood water removal systems including a motor, a vacuum generating device, a discharge pump, and a vacuum tank can be efficiently arranged to be transversely mounted to a vehicle. Certain flood water removal systems can include a supercharger driven by the engine to generate vacuum. The systems can include a valve to prevent collapse of a vacuum tank and maintain a predetermined vacuum pressure without varying the speed of the motor. The systems can also include a two-stage exhaust that blends exhaust from the blower with motor exhaust in a silencer to reduce noise generation for operation in residential or other noise-sensitive settings. The systems can also include a vacuum tank comprising a noise reduction baffle to further reduce noise generation. | 06-16-2011 |
Derek Exner, Calgary CA
| Patent application number | Description | Published |
|---|---|---|
| 20100145207 | METHOD AND SYSTEM FOR DETECTING T-WAVE ALTERNANS - A method for generating a cardiac electrical instability assesment is disclosed herein. The method includes obtaining a SDTWA measurement, obtaining a LDTWA measurement, and obtaining a cardiac electrical instability assessment based on both the SDTWA measurement and the LDTWA measurement. | 06-10-2010 |
Ed Exner, Troy, MI US
| Patent application number | Description | Published |
|---|---|---|
| 20110085864 | TOOL HOLDER ASSEMBLY - A tool holder assembly including a cutting tool and a tool holder. The cutting tool includes at least one fluid passage. The tool holder includes a conduit and a bore adapted to receive the cutting tool. An adapter or adapter portion may be provided that provides a fluid to one or more fluid passages in the cutting tool. | 04-14-2011 |
James Exner, Plano, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20100299630 | HYBRID MEDIA VIEWING APPLICATION INCLUDING A REGION OF INTEREST WITHIN A WIDE FIELD OF VIEW - A content delivery and display solution includes a viewing application for displaying immersive images with a region of interest, in addition to conventional fixed-aspect-ratio media. The display can include the layered display of metadata, multiple windows, and images or hotspots embedded into the immersive image. The viewing application can be used for the display of either live or prerecorded images, from local or online sources. | 11-25-2010 |
Kai Michael Exner, Mumbai Powai IN
| Patent application number | Description | Published |
|---|---|---|
| 20080249307 | Method for Producing Ethylene Amines - Processes are described comprising: (i) providing a reactant comprising 1,2-dichloroethane; and (ii) reacting the reactant with ammonia to form a reaction product comprising one or more ethylene amines and hydrogen chloride, wherein the reaction is carried out in the presence of an organic, nitrogen- or phosphorus-containing compound which reacts with the hydrogen chloride to form an ionic liquid. | 10-09-2008 |
| 20080287684 | Method for Producing Ionic Liquids - The present invention describes a process for preparing ionic liquids (I) by reacting ionic liquids (II) whose anion is a halide with an acid (III), with the resulting hydrogen halide being scavenged by means of an amine and the resulting ammonium halide being able to be separated off. | 11-20-2008 |
Mark Exner, Irvine, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110142687 | FLOOD WATER REMOVAL SYSTEM - Flood water removal systems including a motor, a vacuum generating device, a discharge pump, and a vacuum tank can be efficiently arranged to be transversely mounted to a vehicle. Certain flood water removal systems can include a supercharger driven by the engine to generate vacuum. The systems can include a valve to prevent collapse of a vacuum tank and maintain a predetermined vacuum pressure without varying the speed of the motor. The systems can also include a two-stage exhaust that blends exhaust from the blower with motor exhaust in a silencer to reduce noise generation for operation in residential or other noise-sensitive settings. The systems can also include a vacuum tank comprising a noise reduction baffle to further reduce noise generation. | 06-16-2011 |
Maurice Exner, San Clemente, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20120088242 | ASSAY FOR MYCOBACTERIUM AVIUM/INTRACELLULARE NUCLEIC ACID - Disclosed is a method for determining the presence of | 04-12-2012 |
Maurice Exner, Mission Viejo, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090181366 | INTERNAL POSITIVE CONTROL FOR NUCLEIC ACID ASSAYS - Compositions and methods for detecting a non-specific nucleic acid amplification inhibitor in a reaction are disclosed. An internal positive control (IPC) may be included in samples to be tested for target nucleic acids as a means to monitor non-specific inhibition of nucleic acid amplification and provide confidence in negative results obtained in target-specific assays. Provided herein are an IPC polynucleotide, IPC control primers, and IPC probes. Also provided are methods of using an IPC polynucleotide, primers, and probes to detect a non-specific nucleic acid amplification inhibitor. | 07-16-2009 |
| 20100291583 | METHODS FOR DETECTING NUCLEIC ACIDS USING MULTIPLE SIGNALS - Disclosed is are methods for identifying a nucleic acid in a sample. In one example, the method includes: (a) contacting the nucleic acid in the sample with an oligonucleotide that is specific for the nucleic acid in the sample and that is labeled with at least a first fluorescent dye; (b) contacting the nucleic acid in the sample with a second fluorescent dye that is different from the first fluorescent dye, such that the second fluorescent dye interacts with the nucleic acid; (c) amplifying the nucleic acid if present in the sample; and (d) detecting the nucleic acid if present in the sample by observing fluorescence from the first fluorescent dye after the oligonucleotide hybridizes to the amplified nucleic acid and determining the melting temperature of the amplified nucleic acid by measuring the fluorescence of the second fluorescent dye. The second fluorescent dye may include a fluorescent intercalating agent. | 11-18-2010 |
| 20110027792 | ASSAY FOR MYCOBACTERIUM AVIUM/INTRACELLULARE NUCLEIC ACID - Disclosed is a method for determining the presence of | 02-03-2011 |
Thomas Exner, Gordon AU
| Patent application number | Description | Published |
|---|---|---|
| 20090221012 | Method for Detecting Procoagulant Phospholipid - The present invention relates to a method for determining the amount of procoagulant phospholipid in a sample, said method comprising steps (i) to (iii) performed in the following order: (i) forming an admixture of the sample and a substrate plasma which has been rendered free or substantially free of procoagulant phospholipid sufficient to at least reduce the capacity of the substrate plasma to coagulate, wherein said substrate plasma has been rendered free or substantially free of procoagulant phospholipid by treatment with a phospholipase; (ii) contacting the admixture with a reagent for activating coagulation of plasma in conditions were procoagulant phospholipids is the rate limiting component of the mixture; and (iii) determining the clotting time if the admixture. | 09-03-2009 |